Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Daxin Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company focused on the development and large-scale manufacturing of active pharmaceutical ingredients (APIs) and finished drug products. Founded in 1970 and based in Zhengzhou, the company is a key subsidiary of the state-owned China Meheco Group. It is globally recognized for its production of statins, such as Lovastatin and Simvastatin, and macrolide antibiotics like Clarithromycin. The company's facilities are equipped with advanced fermentation and synthesis technologies and hold multiple international quality certifications, including US FDA and EU GMP. Henan Daxin exports its high-quality pharmaceutical products to over 30 countries and regions, maintaining a significant presence in the global supply chain for cardiovascular and anti-infective medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Daxin Pharmaceutical.